John B. Hogan

627 total citations
16 papers, 516 citations indexed

About

John B. Hogan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, John B. Hogan has authored 16 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in John B. Hogan's work include Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). John B. Hogan is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). John B. Hogan collaborates with scholars based in United States, Germany and Canada. John B. Hogan's co-authors include Mark D. Lindner, Donald B. Hodges, Michael R. Landauer, Carl A. Castro, Kimberly Benson, Jason A. Corsa, Kevin W. Gillman, Valentin K. Gribkoff, Kelly Jones and Etan J. Markus and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

John B. Hogan

16 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John B. Hogan United States	12	203	160	117	78	69	16	516
Wynn H.T. Pan Taiwan	18	227 1.1×	189 1.2×	98 0.8×	83 1.1×	41 0.6×	40	639
Wayne D. Beck United States	12	102 0.5×	150 0.9×	39 0.3×	97 1.2×	42 0.6×	22	506
Tilson Ha United States	15	280 1.4×	158 1.0×	80 0.7×	64 0.8×	85 1.2×	39	927
Debra A. Gearhart United States	18	297 1.5×	369 2.3×	72 0.6×	158 2.0×	73 1.1×	24	849
Yunkwon Nam South Korea	15	70 0.3×	250 1.6×	33 0.3×	87 1.1×	303 4.4×	34	697
Tangeng Ma United States	18	425 2.1×	292 1.8×	55 0.5×	87 1.1×	128 1.9×	45	955
Vesna Selaković Serbia	16	153 0.8×	146 0.9×	33 0.3×	44 0.6×	103 1.5×	41	639
Huanhuan Yan China	17	178 0.9×	245 1.5×	90 0.8×	104 1.3×	187 2.7×	48	781
V. G. Skrebitsky Russia	15	248 1.2×	272 1.7×	83 0.7×	70 0.9×	145 2.1×	57	637
Hirotaka Sekiguchi Japan	13	70 0.3×	171 1.1×	58 0.5×	71 0.9×	71 1.0×	43	490

Countries citing papers authored by John B. Hogan

Since Specialization

Citations

This map shows the geographic impact of John B. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Hogan more than expected).

Fields of papers citing papers by John B. Hogan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Hogan. The network helps show where John B. Hogan may publish in the future.

Co-authorship network of co-authors of John B. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of John B. Hogan. A scholar is included among the top collaborators of John B. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John B. Hogan. John B. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Luo, Guanglin, Ling Chen, Shuanghua Hu, et al.. (2013). Heterocyclic modification of a novel bicyclo[3.1.0]hexane NPY1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 23(13). 3814–3817. 2 indexed citations

Hu, Shuanghua, Milind Deshpande, Guanglin Luo, et al.. (2012). Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists. ACS Medicinal Chemistry Letters. 3(3). 222–226. 2 indexed citations

Hodges, Donald B., Mark D. Lindner, John B. Hogan, Kelly Jones, & Etan J. Markus. (2009). Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity. Behavioural Pharmacology. 20(3). 237–251. 56 indexed citations

Bruce, Marc A., Lawrence G. Iben, Gail K. Mattson, et al.. (2008). Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y1 receptor antagonist. European Journal of Pharmacology. 590(1-3). 224–232. 32 indexed citations

Andrew, S.M., K.M. Moyes, Kimberly K. Leslie, et al.. (2008). Factors associated with the risk of antibiotic residues and intramammary pathogen presence in milk from heifers administered prepartum intramammary antibiotic therapy. Veterinary Microbiology. 134(1-2). 150–156. 15 indexed citations

Lindner, Mark D., John B. Hogan, R. M. Krause, et al.. (2006). Soluble Aβ and cognitive function in aged F-344 rats and Tg2576 mice. Behavioural Brain Research. 173(1). 62–75. 17 indexed citations

Lindner, Mark D., Clotilde Bourin, Ping Chen, et al.. (2006). Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.. Experimental and Clinical Psychopharmacology. 14(1). 42–51. 14 indexed citations

Gillman, Kevin W., Graham S. Poindexter, Wendy Clarke, et al.. (2006). Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(16). 5517–5526. 17 indexed citations

Lindner, Mark D., John B. Hogan, Donald B. Hodges, et al.. (2006). Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping. Psychopharmacology. 188(4). 629–640. 54 indexed citations

10.

Hogan, John B., Donald B. Hodges, Snježana Lelas, et al.. (2004). Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests. Psychopharmacology. 178(4). 410–419. 21 indexed citations

11.

Lindner, Mark D., Donald B. Hodges, John B. Hogan, et al.. (2003). An Assessment of the Effects of Serotonin 6 (5-HT6) Receptor Antagonists in Rodent Models of Learning. Journal of Pharmacology and Experimental Therapeutics. 307(2). 682–691. 84 indexed citations

12.

Landauer, Michael R., et al.. (2001). Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR‐151327. Journal of Applied Toxicology. 21(1). 25–31. 25 indexed citations

13.

Hogan, John B., et al.. (1998). Toxicological Evaluation of Depleted Uranium in Rats: Six-Month Evaluation Point. 4 indexed citations

14.

Miller, Alexandra C., Alfred F. Fuciarelli, William E. Jackson, et al.. (1998). Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagenesis. 13(6). 643–648. 76 indexed citations

15.

Hogan, John B., et al.. (1996). Establishment of an animal model to evaluate the biological effects of intramuscularly embedded depleted uranium fragments. Technical report. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 2 indexed citations

16.

Castro, Carl A., et al.. (1995). Behavioral effects of vehicles: DMSO, ethanol, Tween-20, Tween-80, and emulphor-620. Pharmacology Biochemistry and Behavior. 50(4). 521–526. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact